Compare IROQ & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IROQ | ASRT |
|---|---|---|
| Founded | 1883 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.6M | 76.0M |
| IPO Year | 2011 | 2004 |
| Metric | IROQ | ASRT |
|---|---|---|
| Price | $27.35 | $11.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 5.0K | ★ 29.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | ★ 140.35 | 95.07 |
| EPS | ★ 0.84 | N/A |
| Revenue | N/A | ★ $124,961,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.42 |
| P/E Ratio | $33.21 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.01 | $0.51 |
| 52 Week High | $29.00 | $12.95 |
| Indicator | IROQ | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 51.22 |
| Support Level | $27.34 | $0.69 |
| Resistance Level | $27.93 | $12.75 |
| Average True Range (ATR) | 0.19 | 0.47 |
| MACD | -0.05 | -0.18 |
| Stochastic Oscillator | 1.19 | 40.00 |
IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.